Two Stocks In Rakesh Jhunjhunwala’s Holdings Lost Up To 40% In 2017
Dec 29, 2017 | 14:37 PM IST
Dec 29, 2017 | 14:37 PM IST
Celebrity investor Rakesh Jhunjhunwala, well known for picking multi-bagger stocks. Had a wonderful year. However, as some of his stocks performed exceptionally well, some incurred huge losses. In 2017, there are two stocks which have caused massive losses. Pharma giant Lupin lost more than 40% since January 2017.
Lupin, one of the crowning jewel of Rakesh Jhunjhunwala's portfolio, lost around 12.5% in the just last 3 months. The data from BSE shows that Rakesh Jhunjhunwala held 1.89% stake in Lupin by the end of September-17 quarter. Interestingly, the stock market wizard had increased his stake from his previously 1.76% just a quarter before. By the end of September-17 quarter, Jhunjhunwala held 85,48,105 shares of Lupin Ltd which amounts to a Rs.866.13 crore. As the company took a plunge in the value of shares, his stake now stands at Rs.762 crore according to todays's price. This means he incurred loss of close to Rs.100 crore just three months period.
Similerly, another favourite stock of Jhunjhunwala - CRISIL caused heavy losses for the master investor. Jhunjhunwala held 5.6% stake in the company which translates into 40 lakh shares amounting to Rs.881.2 crore in January. At current prices of Rs.1,857.05, his stake in the Crisil amounts to Rs.742 crores, which means he had to bear a loss of more than Rs.140 crores in just a years time. The value of CRISIL shaves has lost more than 18% in the year so far. As at the end of September-17, Jhunjunwala still holds 40 lakh shares in the company translating to 5.58 % stake.
At Niveza India Pvt Ltd., we all come to work everyday to take the challenges of stock market head on and to change people's perception that stock market investment is like a gamble. Over the years, we have built our profile as a company which has brought optimum value to our subscribers through our well-researched stock recommendations.... More>>
Disclaimer: Niveza does not guarantee the accuracy or completeness of information on the site, nor does Niveza assume any liability for any loss that may result from reliance upon any such information or recommendations. Information and recommendations on the site are for general information only. Nothing contained herein is an offer to sell nor solicitation to buy any securities.